middl
east
respiratori
syndrom
coronaviru
merscov
transmiss
dromedari
human
result
major
outbreak
middl
east
although
livestock
anim
speci
shown
suscept
merscov
fulli
understood
spread
viru
anim
speci
observ
field
studi
use
rabbit
character
transmiss
potenti
merscov
line
presenc
merscov
receptor
rabbit
nasal
epithelium
high
level
viral
rna
shed
nose
follow
viru
inocul
howev
unlik
merscovinfect
dromedari
rabbit
develop
clinic
manifest
includ
nasal
discharg
shed
limit
amount
infecti
viru
nose
consist
transmiss
contact
airborn
rout
observ
rabbit
data
indic
despit
rel
high
viral
rna
level
produc
low
level
infecti
viru
excret
upper
respiratori
tract
rabbit
compar
dromedari
camel
thu
result
lack
viral
transmiss
middl
east
respiratori
syndrom
coronaviru
merscov
novel
pathogen
known
infect
dromedari
camel
human
seroepidemiolog
studi
indic
viru
circul
dromedari
camel
arabian
peninsula
africa
decad
merscov
sequenc
obtain
camel
larg
similar
obtain
human
mer
case
correspond
region
thu
provid
evid
dromedari
camel
act
zoonot
sourc
viru
howev
mani
primari
human
mer
case
histori
direct
contact
anim
suggest
presenc
unidentifi
rout
humantohuman
transmiss
involv
anim
speci
spread
viru
human
besid
dromedari
camel
anim
speci
ie
llama
alpaca
pig
shown
suscept
develop
upper
respiratori
tract
infect
upon
experiment
intranas
merscov
inocul
line
express
merscov
receptor
dipeptidyl
nasal
epithelium
merscovseroposit
llama
alpaca
report
field
merscovexperimentallyinocul
alpaca
also
shown
transmit
viru
via
contact
understand
zoonot
potenti
merscov
crucial
delin
factor
involv
spread
viru
among
dromedari
well
anim
speci
order
gain
insight
factor
perform
merscov
transmiss
experi
rabbit
previous
shown
rabbit
suscept
merscov
develop
upper
lower
respiratori
tract
infect
upon
viru
inocul
recipi
rabbit
hous
merscovinocul
donor
rabbit
either
adjac
cage
determin
whether
merscov
transmit
via
contact
airborn
rout
respect
donor
rabbit
found
shed
high
level
viral
rna
limit
amount
infecti
viru
thu
potenti
restrict
merscov
transmiss
anim
vivo
experi
studi
perform
use
passag
human
isol
merscov
emc
strain
passag
isol
merscov
genbank
acc
propag
vero
cell
describ
earlier
isol
year
old
qatari
man
develop
sever
pneumonia
pcr
confirm
merscov
infect
anim
experi
approv
perform
accord
guidelin
institut
anim
welfar
committe
approv
juli
approv
septemb
approv
novemb
studi
perform
biosafeti
level
condit
compar
whether
differ
rout
merscov
inocul
gener
similar
clinic
outcom
twelv
new
zealand
rabbit
oryctolagu
cuniculu
specif
pathogen
free
seroneg
merscov
divid
four
group
anim
inocul
ketaminemedetomidin
anesthesia
either
intranas
tcid
ml
merscov
b
intranas
ml
tcid
ml
merscov
c
intranas
tcid
ml
merscov
intratrach
ml
tcid
ml
merscov
intranas
ml
pb
intranas
inoculum
divid
equal
nostril
nasal
throat
swab
obtain
daili
day
day
post
inocul
anim
sacrif
day
respiratori
tract
tissu
collect
compar
clinic
outcom
merscov
emc
strain
strain
ten
new
zealand
rabbit
divid
two
group
inocul
ml
tcid
ml
merscov
strain
intranas
nasal
throat
swab
obtain
day
day
post
inocul
anim
sacrif
day
studi
merscov
transmiss
modifi
version
previous
describ
influenza
viru
ferret
transmiss
setup
use
setup
consist
two
clear
polymethyl
methacryl
cage
differ
size
donor
rabbit
direct
contact
recipi
hous
cage
cm
cm
cm
w
h
l
wherea
airborn
recipi
hous
cage
cm
cm
cm
w
h
l
cage
separ
two
stainless
steel
grid
cm
apart
prevent
direct
contact
still
allow
airflow
donor
rabbit
airborn
recipi
rabbit
transmiss
cage
allow
experi
conduct
neg
pressur
isol
facil
hepafilt
airflow
ms
sinc
cage
small
new
zealand
rabbit
chose
smallers
breed
netherland
dwarf
rabbit
oryctolagu
cuniculu
merscov
transmiss
experi
use
male
femal
rabbit
age
virus
rang
year
experi
first
three
merscov
seroneg
netherland
dwarf
rabbit
inocul
intranas
ml
tcid
ml
merscov
strain
per
nostril
show
equal
suscept
merscov
new
zealand
rabbit
nasal
throat
swab
obtain
daili
day
post
inocul
anim
sacrif
day
respiratori
tract
tissu
collect
viru
transmiss
experi
twelv
netherland
dwarf
rabbit
randomli
distribut
four
individu
hous
group
one
rabbit
group
inocul
intranas
ml
tcid
ml
merscov
per
nostril
thu
act
donor
rabbit
two
rabbit
use
direct
contact
airborn
recipi
respect
donor
direct
contact
anim
sex
anim
sacrif
day
post
exposur
blood
collect
assess
seroconvers
nasal
swab
throat
swab
respiratori
tract
tissu
sampl
evalu
presenc
infecti
viru
viru
titrat
viral
rna
rtqpcr
upe
gene
previous
describ
sampl
cycl
threshold
less
forti
consid
posit
merscov
rna
viral
rna
quantifi
genom
equival
ge
use
merscov
strain
emc
contain
tcid
ml
calibr
viru
titrat
perform
serial
dilut
vero
cell
cell
monitor
light
microscop
day
cytopath
effect
amount
infecti
viru
swab
sampl
calcul
determin
tcid
statist
analysi
perform
use
graphpad
prism
program
la
jolla
ca
usa
kruskalw
test
appli
due
nonnorm
distribut
data
priorli
determin
shapirowilk
test
signific
differ
group
determin
pvalu
respiratori
tract
tissu
sampl
collect
formalin
embed
paraffin
patholog
analysi
hematoxylineosin
stain
perform
histopatholog
analysi
presenc
merscov
nucleoprotein
merscov
rna
detect
immunohistochemistri
insitu
hybrid
respect
use
previous
publish
protocol
local
respiratori
tract
noninfect
new
zealand
rabbit
analyz
use
optim
immunohistochem
assay
collect
serum
sampl
test
merscov
neutral
antibodi
use
viru
neutral
assay
merscov
antibodi
use
merscov
elisa
accord
previous
publish
protocol
goat
antirabbit
igg
conjug
hrp
dako
glostrup
denmark
use
secondari
antibodi
elisa
rabbit
smallest
anim
speci
natur
infect
merscov
previous
report
develop
upper
lower
respiratori
tract
infect
upon
merscov
inocul
suggest
express
viral
receptor
locat
use
immunohistochemistri
analyz
express
rabbit
respiratori
tract
tissu
upper
respiratori
tract
strongli
express
apic
surfac
nasal
respiratori
olfactori
epithelium
figur
lower
respiratori
tract
present
bronchiolar
alveolar
epitheli
cell
although
variat
express
observ
throughout
lung
either
absent
limitedli
express
alveolar
type
ii
cell
express
alveolar
type
ii
cell
figur
thu
data
highlight
broad
express
respiratori
tract
differ
human
merscov
strain
isol
sinc
strain
first
character
howev
studi
evalu
phenotyp
differ
strain
anim
current
lack
investig
whether
recent
merscov
strain
replic
differ
rabbit
comparison
emc
strain
found
rabbit
inocul
merscov
emc
strain
strain
develop
equal
mild
infect
shed
similar
level
viral
rna
nasal
throat
swab
figur
follow
result
merscov
transmiss
experi
perform
use
strain
recent
strain
two
type
ii
cell
indic
arrow
type
cell
arrowhead
nasal
epithelium
bronchiolar
epithelium
pictur
taken
magnif
alveolar
epithelium
isotyp
control
show
background
signal
assay
previou
studi
inocul
rabbit
intranas
intratrach
intratrach
inocul
quit
invas
thu
requir
skill
oper
minim
procedurerel
damag
respiratori
tract
contrast
intranas
inocul
less
invas
use
studi
infect
rabbit
merscov
investig
whether
intranas
merscov
inocul
suffici
induc
upper
lower
respiratori
tract
infect
rabbit
comparison
combin
intranas
intratrach
inocul
three
new
zealand
rabbit
oryctolagu
cuniculu
inocul
merscov
emc
strain
either
intranas
tcid
ml
group
intranas
ml
tcid
ml
group
b
intranas
tcid
ml
intratrach
ml
tcid
ml
group
c
intranas
pb
neg
control
group
three
group
merscov
inocul
rabbit
develop
minim
clinic
manifest
histopatholog
lesion
amount
viral
rna
shed
nasal
throat
swab
vari
among
inocul
group
figur
b
howev
lung
rabbit
amount
viral
rna
significantli
lower
group
group
b
c
figur
line
observ
fewer
merscovinfect
cell
observ
lung
group
anim
compar
group
b
c
figur
base
result
decid
use
intranas
inocul
ml
tcid
ml
merscov
subsequ
experi
pictur
taken
magnif
alveolar
epithelium
isotyp
control
show
background
signal
assay
differ
human
merscov
strain
isol
sinc
strain
first
character
howev
studi
evalu
phenotyp
differ
strain
anim
current
lack
investig
whether
recent
merscov
strain
replic
differ
rabbit
comparison
emc
strain
found
rabbit
inocul
merscov
emc
strain
strain
develop
equal
mild
infect
shed
similar
level
viral
rna
nasal
throat
swab
figur
follow
result
studi
merscov
transmiss
experiment
set
previous
use
investig
influenza
viru
transmiss
ferret
use
set
consist
two
polymethyl
methacryl
cage
separ
two
steel
grid
cm
apart
setup
small
hous
new
zealand
rabbit
use
smallers
breed
netherland
dwarf
rabbit
prior
viru
transmiss
experi
netherland
dwarf
rabbit
inocul
merscov
qatar
strain
determin
suscept
viru
similar
new
zealand
rabbit
netherland
dwarf
rabbit
shed
viral
rna
nasal
throat
swab
well
respiratori
tract
tissu
upon
intranas
inocul
figur
b
ident
new
zealand
rabbit
merscovinocul
netherland
dwarf
rabbit
develop
clinic
sign
includ
nasal
discharg
show
minim
histopatholog
lesion
immun
cell
infiltr
respiratori
tract
studi
merscov
transmiss
four
netherland
dwarf
rabbit
intranas
inocul
merscov
sixhour
later
cohous
one
rabbit
cage
h
later
anoth
one
cohous
adjac
cage
determin
whether
merscov
could
transmit
contact
andor
airborn
rout
nasal
throat
swab
collect
everi
day
day
post
inoculationexposur
donor
direct
contact
rabbit
respect
day
post
exposur
airborn
recipi
one
viral
rna
infecti
viru
quantifi
sampl
found
donor
rabbit
shed
high
load
viral
rna
nasal
swab
geml
throat
swab
geml
nasal
throat
swab
obtain
day
inocul
day
post
inocul
amount
viral
rna
display
genom
equival
per
ml
geml
dash
line
depict
detect
limit
assay
error
bar
repres
standard
deviat
studi
merscov
transmiss
experiment
set
previous
use
investig
influenza
viru
transmiss
ferret
use
set
consist
two
polymethyl
methacryl
cage
separ
two
steel
grid
cm
apart
setup
small
hous
new
zealand
rabbit
use
smallers
breed
netherland
dwarf
rabbit
prior
viru
transmiss
experi
netherland
dwarf
rabbit
inocul
merscov
qatar
strain
determin
suscept
viru
similar
new
zealand
rabbit
netherland
dwarf
rabbit
shed
viral
rna
nasal
throat
swab
well
respiratori
tract
tissu
upon
intranas
inocul
figur
b
ident
new
zealand
rabbit
merscovinocul
netherland
dwarf
rabbit
develop
clinic
sign
includ
nasal
discharg
show
minim
histopatholog
lesion
immun
cell
infiltr
respiratori
tract
donor
rabbit
day
post
inocul
one
donor
day
throat
swab
infecti
viru
detect
two
donor
day
day
one
contrast
none
swab
recipi
rabbit
posit
viru
titrat
figur
serolog
analysi
sampl
collect
day
exposur
show
donor
rabbit
seroconvert
develop
neutral
antibodi
figur
b
antibodi
respons
directli
inocul
rabbit
rel
low
confirm
result
previou
studi
indic
rabbit
develop
merscov
infect
contact
airborneexpos
rabbit
support
result
viru
titrat
studi
merscov
transmiss
four
netherland
dwarf
rabbit
intranas
inocul
merscov
sixhour
later
cohous
one
rabbit
cage
h
later
anoth
one
cohous
adjac
cage
determin
whether
merscov
could
transmit
contact
andor
airborn
rout
nasal
throat
swab
collect
everi
day
day
post
inoculationexposur
donor
direct
contact
rabbit
respect
day
post
exposur
airborn
recipi
one
viral
rna
infecti
viru
quantifi
sampl
found
donor
rabbit
shed
high
load
viral
rna
nasal
swab
tcid
geml
throat
swab
tcid
geml
amount
viral
rna
shed
inocul
rabbit
remain
high
day
post
inocul
hand
recipi
rabbit
hous
cage
direct
contact
recipi
adjac
cage
airborn
recipi
shed
limit
amount
viral
rna
tcid
geml
nasal
throat
swab
among
four
anim
group
two
direct
contact
recipi
two
airborn
recipi
rabbit
detect
viral
rna
day
post
inocul
nasal
swab
throat
swab
viral
rna
detect
one
direct
contact
recipi
one
airborn
recipi
rabbit
day
post
inocul
figur
b
infecti
viru
detect
low
level
tcid
ml
nasal
throat
swab
donor
rabbit
nasal
swab
donor
rabbit
day
post
inocul
one
donor
day
throat
swab
infecti
viru
detect
two
donor
day
day
one
contrast
none
swab
recipi
rabbit
posit
viru
titrat
figur
serolog
analysi
sampl
collect
day
exposur
show
donor
rabbit
seroconvert
develop
neutral
antibodi
figur
b
antibodi
respons
directli
inocul
rabbit
rel
low
confirm
result
previou
studi
indic
rabbit
develop
merscov
infect
contact
airborneexpos
rabbit
support
result
viru
titrat
current
data
indic
merscov
highli
endem
dromedari
camel
arabian
peninsula
africa
circul
anim
decad
suggest
viru
easili
transmit
dromedari
camel
epidemiolog
point
current
data
indic
merscov
highli
endem
dromedari
camel
arabian
peninsula
africa
circul
anim
decad
suggest
viru
easili
transmit
dromedari
camel
epidemiolog
point
view
import
know
whether
anim
speci
region
may
also
spread
viru
human
anim
speci
vitro
merscov
found
infect
cell
broad
rang
anim
speci
includ
old
new
world
camelid
well
primat
bat
cow
sheep
goat
pig
hors
rabbit
viral
receptor
speci
especi
rabbit
high
similar
human
dromedari
camel
especi
region
interact
spike
protein
thu
facilit
merscov
infect
new
world
camelid
ie
llama
alpaca
shown
seroconvert
merscov
present
region
merscov
circul
may
transmit
viru
current
unclear
besid
camelid
livestock
anim
seem
transmit
viru
human
understand
transmiss
potenti
merscov
perform
viru
transmiss
experi
use
rabbit
anim
model
perform
viru
transmiss
experi
hous
merscovinocul
rabbit
togeth
contact
rabbit
either
adjac
cage
rabbit
develop
upper
lower
respiratori
tract
infect
upon
merscov
inocul
either
via
intranas
combin
intranas
intratrach
rout
line
local
respiratori
tract
epithelium
amount
viral
rna
shed
inocul
rabbit
first
three
day
post
inocul
almost
high
merscovinocul
dromedari
camel
howev
none
direct
contact
airborneexpos
rabbit
develop
clinic
sign
shed
signific
level
viral
rna
shed
infecti
viru
seroconvert
one
possibl
reason
lack
transmiss
limit
amount
infecti
viru
shed
inocul
rabbit
previou
studi
shown
nasal
lung
tissu
experiment
infect
rabbit
infecti
viru
gener
detect
limit
amount
despit
abund
presenc
viral
rna
viru
nucleoprotein
altern
low
level
infecti
viru
transmit
recipi
anim
may
unabl
initi
product
infect
due
presenc
host
protein
restrict
replic
compar
rabbit
merscovinfect
pig
goat
develop
minim
clinic
sign
hardli
shed
infecti
viru
bare
spread
viru
anim
contrast
merscovinfect
dromedari
camel
develop
nasal
discharg
shed
high
amount
infecti
viru
tcid
ml
almost
equal
amount
viral
rna
shed
geml
first
day
post
inocul
interspeci
differ
may
indic
presenc
nasal
discharg
infecti
viru
shed
critic
factor
merscov
transmiss
human
level
infecti
viru
shed
merscov
patient
rare
report
howev
merscov
patient
transmit
viru
shown
shed
higher
amount
viral
rna
swab
compar
support
quantiti
viru
shed
import
factor
transmiss
merscov
human
influenza
virus
infecti
viru
shed
document
one
main
determin
airborn
viru
transmiss
use
ferret
anim
model
report
reduct
infecti
viru
shed
nasal
swab
subsequ
limit
viru
transmiss
result
show
despit
presenc
upper
respiratori
tract
accompani
merscov
replic
site
limit
amount
infecti
viru
shed
similarli
titrat
rabbit
lung
homogen
show
high
level
viral
rna
presenc
nucleoprotein
figur
result
low
level
infecti
viru
line
earlier
observ
stage
clear
host
mediat
mechan
limit
product
infecti
viru
allow
viral
rna
still
shed
high
level
sinc
restrict
infecti
viru
shed
rabbit
alreadi
occur
one
day
post
inocul
activ
host
innat
immun
respons
includ
type
interferon
induct
may
relev
vitro
studi
shown
merscov
rel
sensit
type
interferonmedi
antivir
activ
human
plasmacytoid
dendrit
cell
merscov
inocul
lead
secret
larg
amount
type
iii
interferon
product
viral
rna
hardli
infecti
viru
produc
also
possibl
infecti
viru
shed
rabbit
defect
lack
capac
effici
infect
target
cell
studi
need
elucid
mechan
restrict
merscov
replic
rabbit
compar
dromedari
camel
potenti
merscov
accessori
protein
shown
antagon
immun
respons
includ
product
interferon
may
work
effici
merscov
suscept
speci
includ
rabbit
intrigu
investig
whether
similar
phenomenon
occur
human
merscov
infect
whether
link
develop
asymptomat
mild
clinic
manifest
might
partli
explain
merscov
transmiss
human
rather
ineffici
comparison
dromedari
camel
camelid
secret
high
level
infecti
viru
known
zoonot
sourc
merscov
deciph
mechan
could
potenti
offer
insight
understand
merscov
transmiss
well
develop
novel
treatment
tackl
ongo
outbreak
